A Pharmacokinetic and Safety Assessment of G3139 Administered by Subcutaneous Injection to Patients With Solid Tumors
Phase of Trial: Phase I
Latest Information Update: 11 Oct 2007
At a glance
- Drugs Oblimersen (Primary)
- Indications Solid tumours
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Genta
- 11 Oct 2007 Status changed from in progress to completed.
- 14 Jun 2007 New trial record.